According to Day One Biopharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.50. At the end of 2025 the company had a P/S ratio of 5.05.
Year | P/S ratio | Change |
---|---|---|
2025 | 5.05 | -48.95% |
2024 | 9.90 | |
2023 | N/A | |
2022 | N/A | |
2021 | N/A |